No Detail Found!

Hypoalbuminemia in COVID-19 patients: A Predictor of Poor Outcome

Author(s)
MUBASHAR SULTAN HASHMI Services Institute of Medical Sciences,Lahore,Pakistan
MUDASSAR ASHRAF Abu Ummara Medical College, Ali Fatima Teaching Hospital,Lahore,Pakistan
UMBREEN ASLAM Fatima Jinnah Medical University, Sir Ganga Ram Hospital,Lahore,Pakistan
MUHAMMAD SOHAIL KHALID Department of Gasroenterology, Continental Medical College, Lahore, Pakistan
ZAHRA NAWAZ DHQ Hospital,Layyah,Pakistan
MUHAMMAD ASIM RANA Department of Critical Care Medicine, Amna Inayat Medical College/ Consultant Bahria International Hospital Lahore, Pakistan
MUHAMMAD MANSOOR HAFEEZ Research and Development Expert Doctors, PVT, LTD, Lahore, Pakistan
Abstract
Background: The coronavirus disease 2019 (COVID-19) has quickly spread to become a pandemic. Most studies demonstrate that increased liver enzymes in COVID-19 have little clinical relevance. In severe COVID-19, lower albumin levels are seen. Aim: To see how hypoalbuminemia levels affect the COVID-19 patients. Study design: Retrospective cohort study. Place and duration of study: Services Institute of Medical Sciences Lahore and Bahria International Hospital, Lahore from 10th January 2021 to 17th September 2021. Methodology: Sixty-seven confirmed cases of COVID-19 on RT-PCR were recruited. They were further divided into two groups. Group N (normal albumin levels) had thirty-six participants whereas group HA (hypoalbuminemia) contained thirty-one participants. Both males and females of all age groups, having complete medical records were included. Biochemical variables were noted from the medical record within 48 to 72 hours after admission. Twenty eight days follow up was done to note the mortality. Patients having incomplete medical records who expired within 2 days after admission were excluded. Results: A significantly higher number of deaths, lymphopenia, hypertensive, diabetics, and asthmatic participants were found in Group HA as compared to Group N. Hypoalbuminemia is mostly seen in older age and biochemical variables such as total leukocyte count and, neutrophils were elevated, whereas lower levels of lymphocytes were found in group HA. Lower lymphocytes and higher creatinine levels are the most prevalent predictors of mortality. The Pearson's correlation of albumin with lymphocytes showed a positive correlation and inverse correlation with TLC, Neutrophil counts, CRP levels Conclusion: The group HA is associated with higher mortality and increased levels of prognostic factors of mortality.
Publication Details
Page(s) 74-76
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Request the full text from PASTIC

Keywords
Mortality, SARS-CoV-2, hypoalbuminemia, Therapeutic benefits, Predictive importance, Inflammatory markers
References
Contini C,Di Nuzzo M,Nicole B,Bonazza A .2020 .The novel zoonotic COVID-19 pandemic: an expected global health concern. J Infec Developing Countries, 14 : 254-64.
.2021 .Vaccines and routine immunization strategies during the COVID-19 pandemic. Human Vaccines Immunotherap, 17 : 400-7.
.2020 .Cardiotoxicity of contemporary anticancer immunotherapy. Curr Treatment Options Cardiovasc Med, 22 : 1-15.
Huang W,Li C,Wang Z,Wang H,Zhou N,Jiang J .2020 .Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases. Sci China Life Sci, 63 : 1678-87.
Wang Z,Du Z,Zhu F .2020 .Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Practice, 164 : 108214.
Mazzaferro EM,Rudloff E,Kirby R .2002 .The role of albumin replacement in the critically ill veterinary patient. J Veter Emerg Crit Care, 12 : 113-24.
Alhazzani W,Moller MH,Arabi YM,Loeb M,Gong MN,Fan E .2020 .Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med, 46(5) : 854-87.
Aziz M,Fatima R,Lee-Smith W,Assaly R. .2020 .The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Crit Care, 24 : 1-4.
Huang J,Cheng A,Kumar R,Fang Y,Chen G,Zhu Y .2020 .Hypoalbuminemia predicts the outcome of COVID‐19 independent of age and co‐morbidity. J Med Virol, 92(10) : 2152-8.
Kheir M,Saleem F,Wang C,Mann A,Chua J .2021 .Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19. Plos One, 16 : e0248358.
Soetedjo NNM,Irvaningrum MR,Damara FA,Permadhi I,Sutanto LB,Hartono H .2021 .Prognostic properties of hypoalbuminemia in COVID19 patients: a systematic review and diagnostic meta-analysis. Clin Nutr, 45 : 120-26.
Cui Z,Merritt Z,Assa A,Mustehan H,Chung E,Liu S .2021 .Early and significant reduction in c‐reactive protein levels after corticosteroid therapy is associated with reduced mortality in patients with COVID‐19. J Hospital Med, 16(3) : 142-8.
Gao S,Jiang F,Jin W,Shi Y,Yang L,Xia Y .2002 .Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan, China. Aging (Albany NY). , 12(13) : 12504-16.
McNeil JB,Jackson KE,Wang C,Siew ED,Vincz AJ,Shaver CM .2021 .Linear association between hypoalbuminemia and increased risk of acute respiratory distress syndrome in critically ill adults. Crit Care Explor, 3(9) : e0527.
Tsibouris P,Ekmektzoglou K,Agorogianni A,Kalantzis C,Theofanopoulou A,Toumbelis K .2020 .Gastrointestinal involvement in COVID-19 patients: a retrospective study from a Greek COVID-19 referral hospital. Ann Gastroenterol, 33(5) : 465-72.
Paliogiannis P,Mangoni AA,Cangemi M,Fois AG,Carru C .2021 .Zinellu A. Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta-analysis. Clin Exp Med, 21(3) : 343-54.
Cichoż-Lach H,Michalak A .2021 .Liver injury in the era of. COVID-19. World J Gastroenterol, 27 : 377.
Chen C,Zhang Y,Zhao X,Tag M,Yan W,Fu Y .2021 .- an indicator of the severity and prognosis of COVID-19 patients: a multicentre retrospective analysis. Infec Drug Resistance, : 3699-3710.
Bertolini A,van de Peppel IP,Bodewes FAJA,Moshage H,Fantin A,Farinati F .2020 .Abnormal liver function tests in patients with COVID‐19: relevance and potential pathogenesis. Hepatology, 72(5) : 1864-72.
Soeters PB,Wolfe RR,Shenkin A .2019 .Hypoalbuminemia: pathogenesis and clinical significance. J Parenteral Enteral Nutr, 43 : 181-93.
Artigas A,Wernerman J,Arroyo V,Vincent JL,Levy M. .2016 .Role of albumin in diseases associated with severe systemic inflammation: pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis. J Crit Care, 33 : 62-70.
Uhlig C,Silva PL,Deckert S,Schmitt J .2014 .Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care, 18 : 1-8.
0

Citations

0

Downloads

54

Views